that are substantially larger than predicted by amino acid sequences (5, 15, 19, 34, 35) . 23 Furthermore, the major immunodeterminants have been mapped to acidic serine-rich tandem 24 repeats in many of these proteins (5, 19, 33, 35) . 25 Recently, the largest major immunoreactive ehrlichial protein orthologs (gp200) of E. 26
canis and E. chaffeensis has been identified and molecularly characterized (15) . The 27 recombinant E. canis gp200 N-terminal domain (P43) reacts strongly with antibodies in serum 28 from dogs naturally and experimentally infected with E. canis (16, 17) . The native and 29 recombinant E. chaffeensis and E. canis gp200 orthologs exhibit molecular masses larger than 30 predicted by their amino acid sequences, but lack serine-rich tandem repeats present in other 31 ehrlichial proteins (15) . However, the gp200s have ankyrin domains containing numerous 32 ankyrin repeats (at least 21) that may mediate protein-protein interactions. The function of the 33 gp200 is unknown, but the protein is translocated to the nucleus of infected monocytes (23) . The 34 gp200 exhibits homology with Anaplasma phagocytophilum AnkA (3), which is a type IV 35 secretion substrate and is phosphorylated by host Abl-1 and Src tyrosine kinases (8, 13) . AnkA 36 also translocated to the nucleus of infected neutrophils where it binds DNA and may be involved 37 in modulation of host cell gene transcription (26) . 38 humoral immunity in host defenses against ehrlichial pathogens (7, (30) (31) (32) . Immunocompetent 42 mice lacking B cells cannot clear a sublethal infection with Ixodes ovatus ehrlichia (32) , and 43 adoptive transfer of polyclonal immune serum protects severe combined immunodeficiency 44 (SCID) mice from E. chaffeensis challenge (7) . Specifically, protection has been demonstrated 45 with antibodies directed against the p28 of E. chaffeensis (11, 12, 25, 30) , and studies with E. canis 46 demonstrated that opsonization with antibodies resulted in the intracellular killing of the 47 organism in vitro (10). SCID mice are protected from lethal infection by passive transfer of anti-48 E. muris polyclonal antibody, but Fab antibody fragments are not protective (7) . 49
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The objective of this study was to define the epitopes involved in antibody recognition of 50 the gp200, a well characterized immunoreactive ehrlichial protein. In this study, we determined 51 that the gp200 contains at least five major immunoreactive epitopes the majority of which were 52 localized to terminal domains dominated by strongly acidic amino acids. These domains appear 53 to have important biophysical properties that influence the antibody response against gp200. 54
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Correct donor vectors were recombined by Cre recombinase with the pRSET-E Echo acceptor 78 vector (Invitrogen), which contains a loxP recombination site. Recombined vectors were 79 transformed into TOP10 E. coli (Invitrogen) for plasmid propagation, and transformants were 80 selected by growth on LB agar with kanamycin (50 µg/ml). Correct orientation and frame of the 81 transformant inserts were verified as described above. These clones and the control plasmid 82
pRSET-E/Uni-CAT (Invitrogen) were transformed into BL21 (DE3) pLysS E. coli (Invitrogen), 83 and protein expression was induced by addition of 1 mM isopropyl-β-D-thiogalactopyranoside 84 (IPTG) to a liquid culture in log growth phase at incubated for 3.5 hrs at 37° C. Following 85 expression, cultures were pelleted at 3,000 x g for 20 min and frozen at -80° C. 86
All smaller recombinant E. canis gp200 fragments used for epitope mapping were 87 amplified by PCR, cloned into the pBAD/TOPO ThioFusion expression vector (Invitrogen) and 88 characterized similarly. Expression of the recombinant proteins in TOP10 E. coli (Invitrogen) 89 was induced by adding 0.02 % arabinose to cultures in log phase growth. The recombinant E. 90 canis gp200 proteins expressed from the recombined pUni/pRSET-E Echo vector were purified 91 under denaturing conditions as described previously (5, 16) . The recombinant peptides expressed 92 from the pBAD/TOPO ThioFusion vectors were purified under native conditions as previously 93 described (6) encoding all epitopes (14-or 15-mer peptides) ( Table 2) were annealed and cloned into the 98 pBAD 102/Directional TOPO ThioFusion expression vector (Invitrogen) as previously described 99 (5) . 100 Recombinant proteins/peptides were transferred to a nitrocellulose membrane as described 107 previously (17) . 108
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109
Western immunoblot. Immunoreactivity of recombinant gp200 fragments with anti-E. canis 110 dog serum (#2995) was determined by Western immunoblotting as previously described (17) 
RESULTS
138
Gp200 amino acid composition and acidic domains. The overall gp200 (1421 amino acids) 140 composition was predominated by four hydrophobic (A, I, L, V), four polar (S, T, N, Q), two 141 strongly acidic (D and E; 187 amino acids) and two strongly basic (K and R; 144 amino acids), 142 amino acids. Interestingly, a large number (n=118) of glycine (G) residues (high content in 143 fibrous proteins) were also present. Three specific domains were identified according to amino 144 acid composition and isoelectric point ( fragments (containing the acidic domains) exhibited substantially larger (~ 6 kDa) than predicted 158 molecular masses by SDS-PAGE ( Fig. 2A) . Three gp200 recombinant fragments (Nt, Ci, and 159 Ct) reacted strongly with anti-E. canis antibody, but the Ni polypeptide exhibited a substantially 160 weaker immunoreactivity (Fig. 2B ). The recombinant proteins (Nt, Ni, Ci, Ct) did not react with 161 normal dog sera (data not shown). Thus, the three strongly immunoreactive fragments (Nt, Ci, 162 and Ct) were considered to have major B cell epitopes and were investigated further. 163
Major epitope-containing region in the Nt polypeptide. The major epitope(s) in the Nt region 165 were identified by evaluating the immunoreactivity of six overlapping recombinant proteins (Fig.  166   3A) . A smaller recombinant protein representing approximately one half (amino acids 8-186) of 167 the Nt region of gp200 was cloned and expressed, and Western blotting revealed that this smaller 168
Nt polypeptide (designated Nt ) was strongly reactive with dog anti-E. canis serum (Fig. 3B) . 169 (Fig. 3B) . The region from amino acid 36 to 85 was identified in the strongly 173 immunoreactive recombinant polypeptides but not in weakly reactive fragments; thus this 51-174 amino acid section of the E. canis gp200 was identified as the major epitope-containing region 175
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and was located in a highly acidic domain ( Fig. 1 and Fig. 3C ). This polypeptide exhibited high 176 serine/threonine/glutamate/aspartate (STED) content (~31%) ( Table 3) . Ci 933-985 , and Ci 942-985 spanned amino acids 756 to 1024. However, the major epitope-containing 184 region was identified by excluding the amino acids contained within the remaining polypeptides 185 which were only weakly immunoreactive or not immunoreactive (Fig. 3B) . Therefore, the major 186 epitope-containing region was located within amino acids 948 to 978 (Fig. 3C) , which also 187 exhibited a high STED content (~29%) ( Table 3) . 188
189
Major epitope-containing region in the Ct polypeptide. The epitope-containing regions in the 190
Ct region of the E. canis gp200 were identified by evaluating the immunoreactivity of smaller 191 overlapping recombinant proteins (Fig. 3A) . The large Ct region was divided roughly in half and 192 The immunoreactivity of the distal half of the protein was strong, as determined by Western blot 194 with anti-E. canis dog serum (Fig. 3B) (Fig. 3B) . The epitope-containing regions within the Ct region of E. 200 canis gp200 were determined by excluding the amino acids contained by the two weakly 201 immunoreactive recombinant proteins: 1266-1340. Therefore, the regions including amino 202 acids 1222-1290 and 1372-1404 were considered Ct epitope-containing regions and were located 203 in higly acidic domains ( Fig. 1 and Fig. 3C ). Both epitope containing regions had high STED 204 content, 27 % and 24%, respectively (Table 3) . (Table 3) . 216
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Western immunoblot and ELISA were performed to determine the recombinant gp200 217 peptide immunoreactivity, and the immunoreactivity of the synthetic peptides was evaluated by 218 ELISA. Recombinant peptides 2, 5, 9, 15, and 20 exhibited strong immunoreactivity, and 219 peptides 8, 11, 16 and 19 were weakly immunoreactive by Western blot (Fig. 4B) . Seven 220 recombinant peptides: 2, 5, 8, 9, 15, 19, and 20, were strongly immunoreactive by ELISA and 221
were not identified by BLASTp as having significant homology with E. chaffeensis gp200 or any 222 other ehrlichial protein (Fig. 4C) . Most synthetic peptides exhibited reduced immunoreactivity 223 compared to the corresponding recombinant expressed fusion polypeptides indicating a 224 conformational dependence of these epitopes (Fig. 4C) . A 14-mer positive control peptide 225 derived from E. chaffeensis p28-19 was included to demonstrate peptide binding and 226 immunoreactivity and was strongly reactive with convalescent dog anti-E. canis antibodies. 227 228 Serine residues and antibody binding. Serine is a frequently occurring amino acid in 229 immunoreactive ehrlichial proteins and epitopes, and was the second most common (n=121) 230 amino acid present in the gp200. Recombinant peptides 2 and 20 were strongly reactive by 231 ELISA, and each contained a single serine residue. Thus, these peptides were chosen for site-232 directed mutagenesis to examine the contribution of serine residues in antibody binding. Site-233 directed serine mutants (sequences shown in Fig. 5 ) of peptides 2 and 20 were substantially less 234 immunoreactive by ELISA than the corresponding wild-type peptides demonstrating these serine 235 residues are important determinants of these two epitopes. 236 15,16,19,34,35) . Furthermore, dominant antibody 241 epitopes in these proteins have been mapped to acidic serine-threonine-rich regions and serine-242 rich tandem repeats in all of these proteins (5, 19, 33, 35) . Thus, serine-rich acidic epitopes appear 243 to be primary targets of the humoral immune responses against ehrlichiae and may be 244
immunoprotective. In this study, five species-specific epitopes were identified primarily in 245
terminal highly acidic domains of the E. canis gp200. 246
The E. canis and E. chaffeensis gp200 orthologs have identical chromosomal location and 247 exhibit nucleic acid homology (~50 %), but have less amino acid identity (~32 %) (15) . We 248 previously reported that the N-terminal region (P43) (analogous to the Nt in this study) of the 249 gp200 was strongly recognized by antibody from E. canis infected dogs and antibodies directed 250 at the P43 were species-specific (16) . Ehrlichia are known to have serologically cross-reactive 251 antigens. The best characterized examples are the major outer membrane proteins (p28/p30), 252 map2, and other highly conserved immunoreactive proteins such as the chaperonin GroEL, 253 disulfide oxidoreductase (Dsb), and ferric-ion binding protein (Fbp) (1, 2, 6, 20, 24, 25, 29, 38) . 254
However, several of the epitopes characterized in the major immunoreactive proteins of E. canis 255 and E. chaffeensis are molecularly distinct and elicit species-specific antibodies (5, 19) . 256 Consistent with our previous findings regarding the Nt epitopes (P43), the amino acid alignments 257 of the mapped epitopes in the gp200 (Nt, Ci and Ct) identified no significant homology with the 258 E. chaffeensis gp200. Interestingly, all of the major immunoreactive protein orthologs 259 acids observed in these terminal domains has been consistently observed in other characterized 269 ehrlichial epitopes (5, 19) . Furthermore, most of the characterized immunoreactive ehrlichial 270 proteins (i.e., gp36, gp47, gp19, gp140, gp120, gp200) are strongly acidic (pI ~ 4 to 5.4). The 271 role of the acidic, polar and hydrophobic amino acids, such as glutamate, serine, and valine is not 272 currently understood, but the consistent presence of these amino acids in ehrlichial epitopes 273 suggest they constitute an important motif that interacts strongly with the host immune response. 274
The predominance of antibody response to acidic ehrlichial proteins, particularly those 275 containing tandem repeats has not been described in relation to any other pathogen and suggests 276 that an important and unique ehrlichial-host interaction occurs that directs the immune response 277 towards these proteins. 278
The genome of E. canis has a revealed a serine/threonine bias in proteins associated with 279 host pathogen interactions (14) . The polar amino acid serine was the second most frequently 280 occurring amino acid in the E. canis gp200 (n=121), and the largest proportion of serine and 281 threonine residues (73; 17%) were identified in the Ct region of the E. canis gp200. It is also 282 suggesting that serine residues are critical for the binding of antibodies to these epitopes. 288
Notably, the high frequency of serine residues in immunoreactive ehrlichial proteins including 289 the gp200 has not been reported in other bacteria, but the high frequency of these residues 290
suggests an important role in the pathobiology of ehrlichiae. Furthermore, there appears to be a 291 direct relationship between the host immune response and acidic, serine-rich proteins. 292
Antibody epitopes mapped in other ehrlichial proteins appear to be single epitopes 293 located in acidic serine-rich tandem repeats (5, 19, (33) (34) (35) . However, we found numerous 294 molecularly distinct epitopes in the gp200 that were not located in tandem repeats. The number 295 of epitopes identified in the gp200 suggests that it is an important target of the host immune 296 response against E. canis. Epitopes that have been mapped in other ehrlichial proteins are 297 present in tandem repeat containing proteins that are associated with host pathogen interactions 298 (27, 35) . The gp200 is translocated to the host cell nucleus (23) , which has also been reported for 299
AnkA, a similar ankyrin containing protein found in A. phagocytophilum (26) . Furthermore, 300
AnkA has been proposed to be a type IV secreted virulence factor because of its potential ability 301 to facilitate intracellular infection by activation of host Abl-1 signaling pathway, recruitment of 302 phosphatase SHP-1 and DNA binding (8, 13, 26) . Although the role of antibodies in inhibiting 303 the functional role of E. canis gp200 is unknown, inhibition of gp200 by the host immune 304 response would likely result in an outcome beneficial to the host. 305 (2, 6, 13, 22) . In this case, the strong antibody 310 recognition of the synthetic E. chaffeensis p28-19 peptide demonstrated strong binding by 311 synthetic peptides to the solid substrate used in this study. Therefore, the general lack of 312 immunoreactivity of the synthetic peptides compared to the recombinant fusion gp200 peptides 313 is most likely a result of improved solubility and appropriate epitope folding, resulting in 314 increased antibody binding. 315
The E. canis and E. chaffeensis gp200s are the largest immunoreactive proteins (15, 17) , 316 and these unique ankyrin domain containing proteins warrant further investigation. Gp200 317 specific antibodies are elicited in dogs experimentally and naturally infected with E. canis 318 
